Genome Prairie Announces Appointment of CSO
Genome Prairie announces the appointment of Chris Barker as Chief Scientific Officer. Barker has extensive technical, scientific and management experience through various positions held within […]
Articles by laurakw
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
Aeterna Zentaris Inc. announces the appointment of David A. Dodd to the role of president and CEO. Dodd has also been appointed director on the […]
Automated TruSeq RNA sample preparation from FFPE tissue specimens utilizing the Biomek FXP Liquid Handler
Overview This article describes a TruSeq (Illumina, Inc. San Diego, CA) RNA library preparation method for FFPE samples that uses the Biomek automation platform (Beckman […]
Qu Biologics announces phase 1/2 trial of treatment for Crohn’s disease
Qu Biologics is launching a phase 1/2 clinical trial to evaluate the potential clinical response and disease remission among participants with Crohn’s disease treated with […]
Phase 3 study of integrase inhibitor doluegravir provides potential for HIV-1 adults who have developed resistance to antiretrovirals
ViiV Healthcare today announces 24 week data from the Phase III 48 week SAILING study evaluating the investigational integrase inhibitor dolutegravir for patients who are […]
First treatment for ultra-rare disease, aHUS, receives marketing approval in Canada
Alexion Pharma Canada announces that Health Canada has approved the use of Soliris® (eculizumab) for the treatment of patients with atypical hemolytic uremic syndrome (atypical […]
FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent
Medtronic, Inc. announces Monday that the U.S. Food and Drug Administration (FDA) has approved the 34mm and 38mm lengths of the Resolute Integrity drug-eluting stent […]